Skip to content

Clinical trials

Phase 1/2 Ovarian Neoplasms trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Country / region: Denmark Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20111
20121
20131
20152
20161
20171
20213
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab2
Inge Marie Svane2
Seagen Inc.2
Vejle Hospital2
BioInvent International AB1
European Organisation for Research and Treatment of Cancer - EORTC1
Nordic Society of Gynaecological Oncology - Clinical Trials Unit1
Novakand Pharma AB1
Valerio Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms13
Endometrial Neoplasms5
Carcinoma, Ovarian Epithelial4
Fallopian Tube Neoplasms3
Urinary Bladder Neoplasms3
Uterine Cervical Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Esophageal Neoplasms2
Melanoma2
Prostatic Neoplasms2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.